NCT04877717View on ClinicalTrials.gov

A Study of SHR-A1904 in Patients With Advanced Solid Cancer

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

107

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions

Advanced Solid Cancer

Interventions

DRUG

SHR-A1904

SHR-A1904

Trial Locations (1)

510060

Sun Yat-Sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Shanghai Hengrui Pharmaceutical Co., Ltd.

INDUSTRY